A Novel-Defined Necroptosis-Related miRNA Signature for Forecasting the Prognosis of Low-Grade Glioma

Table 4

Univariate logistic analysis of hsa-miR-148a-3p and clinical parameters.

Characteristics	Total (N)	Odds ratio (OR)	value
WHO grade (G3 vs. G2)	467	1.113 (0.774-1.601)	0.565
1p/19q codeletion (noncodel vs. codel)	529	2.712 (1.863-3.983)	<0.001
Primary therapy outcome (PR&CR vs. PD&SD)	459	0.671 (0.462-0.971)	0.035
Age (>40 vs. ≤40)	529	0.948 (0.674-1.334)	0.761
IDH status (Mut vs. WT)	526	0.036 (0.013-0.083)	<0.001
Gender (male vs. female)	529	0.851 (0.604-1.199)	0.357